rystiggo
(ROZANOLIXIZUMAB)UCB, Inc.
Usage: RYSTIGGO is indicated for treating generalized myasthenia gravis (gMG) in adults who test positive for anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibodies.
Neonatal Fc Receptor Blocker class drugs
2 results
vyvgart
(EFGARTIGIMOD ALFA)argenx USUsage: VYVGART is indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who test positive for anti-acetylcholine receptor (AChR) antibodies.